Trial Profile
An Open label, Randomized, Clinical Trial of Two Regimens to Assess the Safety and Efficacy for Treatment of PKDL Patients in the Indian subcontinent
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 31 May 2017
Price :
$35
*
At a glance
- Drugs Amphotericin B liposomal (Primary) ; Miltefosine
- Indications Leishmaniasis
- Focus Therapeutic Use
- 31 May 2017 New trial record